Detalles de la búsqueda
1.
Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy.
Am J Respir Crit Care Med
; 205(5): 570-579, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34939891
2.
Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models.
Antimicrob Agents Chemother
; 66(4): e0239821, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35315690
3.
Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments.
Antimicrob Agents Chemother
; 66(4): e0231021, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35311519
4.
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
Antimicrob Agents Chemother
; 66(6): e0013222, 2022 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35607978
5.
Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis.
Antimicrob Agents Chemother
; 65(7): e0025321, 2021 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903099
6.
Preserved Efficacy and Reduced Toxicity with Intermittent Linezolid Dosing in Combination with Bedaquiline and Pretomanid in a Murine Tuberculosis Model.
Antimicrob Agents Chemother
; 64(10)2020 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32690647
7.
Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31907182
8.
Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32205344
9.
Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis.
Antimicrob Agents Chemother
; 63(6)2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30936097
10.
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis.
Antimicrob Agents Chemother
; 63(5)2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833432
11.
Advancing the Therapeutic Potential of Indoleamides for Tuberculosis.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010860
12.
Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038265
13.
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
Antimicrob Agents Chemother
; 62(7)2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735562
14.
Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28874368
15.
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis.
Antimicrob Agents Chemother
; 61(9)2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28630203
16.
In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
J Antimicrob Chemother
; 72(8): 2320-2325, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28575382
17.
High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.
Antimicrob Agents Chemother
; 60(7): 4197-205, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27139472
18.
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Antimicrob Agents Chemother
; 60(1): 270-7, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26503656
19.
Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis.
Antimicrob Agents Chemother
; 59(1): 129-35, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25331697
20.
Hyaluronidase impacts exposures of long-acting injectable paliperidone palmitate in rodent models.
bioRxiv
; 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38496644